A Gilead Sciences Inc Employee Looks At A Slide

A Gilead Sciences Inc Employee Looks At A Slide

David Paul Morris/Bloomberg

Gilead Sciences Inc. agreed last month to buy Pharmasset of Princeton, New Jersey, for $10.8 billion, 94 percent more than its 20-day trading average and the highest premium on record for a drug takeover of comparable size, according to data compiled by Bloomberg.